Surprising
Carnosine supplementation tied to a moderate drop in fasting blood glucose in a meta-analysis of 377 people with prediabetes or type 2 diabetes — but it didn't budge body weight or insulin levels.
This meta-analysis suggests carnosine may help control blood sugar in people with prediabetes or type 2 diabetes, but the results come from a small body of early studies and the lack of effect on weight and insulin means the benefit might be specific to this clinical population and the mechanism is unclear.
The analysis of four randomized trials found that supplementing with carnosine or beta-alanine reduced fasting blood sugar and long-term blood sugar control (HbA1c), while also improving beta-cell function. However, it did not affect body mass index, fasting insulin, or most blood fats, indicating the blood sugar benefit may not be linked to weight loss or insulin sensitivity. Because the studies were small and no dose was specified, more research is needed before drawing firm conclusions.
Where this fits in the evidence
This is among the first studies we've indexed on Carnosine for Reduced Fasting Blood Glucose Levels — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- n = 377
- 2025-09-25
- BMC endocrine disorders
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.